T 0638/19 (Disulfide-crosslinked hydrogels/BIOREGEN) of 13.09.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T063819.20220913
- Date of decision
- 13 September 2022
- Case number
- T 0638/19
- Petition for review of
- -
- Application number
- 11823038.2
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- LOW-MODIFICATION BIOCOMPATIBLE HIGH POLYMER SULFHYDRYL-MODIFIED DERIVATIVES, CROSS-LINKED MATERIAL THEREOF, AND USES OF SAID MATERIAL
- Applicant name
- Bioregen Biomedical (Changzhou) Co., Ltd.
- Opponent name
- Strawman Limited
Croma-Pharma Gesellschaft m.b.H. - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 013(1)Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Late-filed evidence - admitted (no)
Inventive step - obvious alternative
Late-filed requests
Late-filed request - requests could have been filed in first instance proceedings (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The appeal is dismissed.
2. The appeal fee is not reimbursed.